Planning the dissemination of scientific and clinical data on a drug to healthcare professionals at scientific congresses and medical society meetings and in peer-reviewed medical journals
Primary author of several IND reports for molecules targeting HMG-CoA reductase, Ras Farnesyltransferase, EGFR2 and Met.
Primary author of IB for Ras Farnesyltarnsferase inhibitor
Reviewed and edited Phase I/IIa clinical protocols for Ras Farnesyltarnsferase inhibitor
Reviewed and edited integrated clinical summary for safety & efficacy data of farnesyltransferase inhibitor
Primary author of animal protocol and several SOPs & protocols for nerve agent research
Primary author of two grant proposals on enzymes as bioscavenger therapeutics
Primary or contributing author of >60 scientific & medical publications
Proficient in MS word, Excel data & graphic processing programs
Familiar with MedDRA terms and adverse event reporting
Familiar with Clinicaltrials.gov (NIH) web site
Knowledgeable in several standard editorial/style conventions